Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Loss

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1993
Invariant chain retains MHC class II molecules in the endocytic pathwayG E Loss, A J Sant
Ochsner Journal|July 4, 2012
Transplant therapy for type 1 diabetes mellitusG E Loss, H P Grewal
Anesthesia and Analgesia|March 1, 1989
Aging: effects on minimum alveolar concentration (MAC) for halothane in Fischer-344 ratsG E Loss, E Seifen, R H Kennedy, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 18, 2001
Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trialJ D Eason, G E Loss, J Blazek, et al.
The Journal of Experimental Medicine|January 1, 1995
The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependentC C Stebbins, G E Loss, C G Elias, et al.
Journal of Cardiothoracic Anesthesia|December 1, 1987
Comparison of cardiac effects of enflurane, isoflurane, and halothane in the dog heart-lung preparationE Seifen, A B Seifen, R H Kennedy, et al.
The Journal of Experimental Medicine|July 1, 1993
Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathwaysG E Loss, C G Elias, P E Fields, et al.
Journal of Cardiothoracic Anesthesia|August 1, 1988
Myocardial recovery from the cardiac depressant effects of enflurane and halothaneA B Seifen, E Seifen, R H Kennedy, et al.
Clinical Transplantation|March 21, 2002
Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary resultsG E Loss, A L Mason, J Blazek, et al.
Clinical Transplantation|July 18, 2013
Excellent liver retransplantation outcomes in hepatitis C-infected recipientsA Kressel, G Therapondos, H Bohorquez, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1993
Invariant chain retains MHC class II molecules in the endocytic pathwayG E Loss, A J Sant
Ochsner Journal|July 4, 2012
Transplant therapy for type 1 diabetes mellitusG E Loss, H P Grewal
Anesthesia and Analgesia|March 1, 1989
Aging: effects on minimum alveolar concentration (MAC) for halothane in Fischer-344 ratsG E Loss, E Seifen, R H Kennedy, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 18, 2001
Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trialJ D Eason, G E Loss, J Blazek, et al.
The Journal of Experimental Medicine|January 1, 1995
The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependentC C Stebbins, G E Loss, C G Elias, et al.
Journal of Cardiothoracic Anesthesia|December 1, 1987
Comparison of cardiac effects of enflurane, isoflurane, and halothane in the dog heart-lung preparationE Seifen, A B Seifen, R H Kennedy, et al.
The Journal of Experimental Medicine|July 1, 1993
Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathwaysG E Loss, C G Elias, P E Fields, et al.
Journal of Cardiothoracic Anesthesia|August 1, 1988
Myocardial recovery from the cardiac depressant effects of enflurane and halothaneA B Seifen, E Seifen, R H Kennedy, et al.
Clinical Transplantation|March 21, 2002
Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary resultsG E Loss, A L Mason, J Blazek, et al.
Clinical Transplantation|July 18, 2013
Excellent liver retransplantation outcomes in hepatitis C-infected recipientsA Kressel, G Therapondos, H Bohorquez, et al.
Pageof 2